000
| 02221nam 2200385zi 4500 |
---|
001 | 9.901682 |
---|
003 | CaOODSP |
---|
005 | 20230707144450 |
---|
006 | m o d f |
---|
007 | cr mn||||||||| |
---|
008 | 210715e202109 onc obs f000 0 eng d |
---|
020 | |a9780660396538 |
---|
040 | |aCaOODSP|beng|erda|cCaOODSP |
---|
043 | |an-cn--- |
---|
045 | |ay1y2 |
---|
086 | 1 |aHP33-4/2021E-1-PDF |
---|
245 | 00|aOpioid and stimulant poisoning hospitalizations : |bsurveillance of opioid- and stimulant-related harms in Canada : January 2016 to March 2021. |
---|
246 | 17|aOpioid and stimulant poisoning hospitalizations : |bJanuary 2016 to March 2021 |
---|
264 | 1|aOttawa, ON : |bHealth Canada = Santé Canada, |cSeptember 2021. |
---|
264 | 4|c©2021 |
---|
300 | |a1 online resource (50 pages) |
---|
336 | |atext|btxt|2rdacontent |
---|
337 | |acomputer|bc|2rdamedia |
---|
338 | |aonline resource|bcr|2rdacarrier |
---|
500 | |aIssued also in French under title: Hospitalisations pour intoxication aux opioïdes et aux stimulants : surveillance des méfaits associés aux opioÏdes et aux stimulants au Canada : Janvier 2016 à mars 2021. |
---|
500 | |aCover title. |
---|
500 | |a"Pub.: 210194." |
---|
504 | |aIncludes bibliographical references. |
---|
520 | |a"These updates include available data on overdoses and deaths involving opioids and/or stimulants from January 2016 to March 2021, where available. Recognizing that harms related to opioids, stimulants, and other substances extend beyond overdoses (poisonings) and deaths, we continue to work with federal, provincial and territorial partners to build a broad understanding of harms and substances involved to better respond to the crisis. Additional studies can also help us plan and tailor actions to achieve better possible outcomes"--Context, page 5. |
---|
650 | 0|aOpioids|xOverdose|zCanada|vStatistics. |
---|
650 | 0|aNarcotics|xOverdose|zCanada|vStatistics. |
---|
655 | 7|aStatistics|2lcgft |
---|
710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
---|
775 | 08|tHospitalisations pour intoxication aux opioïdes et aux stimulants : |w(CaOODSP)9.901684 |
---|
856 | 40|qPDF|s286 KB|uhttps://publications.gc.ca/collections/collection_2021/aspc-phac/HP33-4-2021-1-eng.pdf |
---|